• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019
  • Biovista in World’s Top 20 AI Drug Development Companies March 22, 2019
  • Biovista signs EU-IMI2 research agreement to advance neurotoxicity de-risking in preclinical drug discovery March 15, 2019
  • The increasing importance of predicting AEs & the role of Augmented Intelligence September 10, 2018

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE

Drugs for Parkinson’s and Alzheimer’s

August 27, 2018Alzheimer's, Nervous System Disorders, Parkinson's, Vizit Graphs
Drugs for Parkinson’s and Alzheimer’s

Find drugs common to both Parkinson’s and Alzheimer’s diseases using Biovista Vizit. Explore the live graph.

Parkinson’s disease and Diabetes Type 2

August 27, 2018Diabetes, Metabolic Disorders, Nervous System Disorders, Parkinson's, Vizit Graphs
Parkinson disease and Diabetes Type 2

Incretin mimetics or GLP-1 receptor agonists are commonly used in Type 2 Diabetes. Recent evidence favors their use for the treatment of Parkinson’s disease. Explore the live graph.

Vizit Graphs Tag Cloud

REMICADE RHEUMATOID ARTHRITIS FOXP3 STAPHYLOCOCCUS AUREUS AGING RECEPTOR DIABETES MELLITUS TNF TH17 CELLS IMMUNE RESPONSE PSEUDOMONAS AERUGINOSA STREPTOCOCCUS PNEUMONIAE CD4 IL6 ANGIOGENESIS IL17A CELL DIFFERENTIATION HELICOBACTER PYLORI ESCHERICHIA COLI NEURODEGENERATIVE DISORDERS 1-METHYL-4-PHENYL-1-2-3-6-TETRAHYDROPYRIDINE CTLA4 CANCER CELL PROLIFERATION INFLAMMATION CANDIDA ALBICANS PORPHYROMONAS GINGIVALIS LISTERIA MONOCYTOGENES METFORMIN DOXORUBICIN CELL DIVISION ERBB-2 CELL DEATH CASP3 TP53 INSULIN CLOSTRIDIUM DIFFICILE IFNG BREAST CANCER IL23A ALZHEIMER'S DISEASE APOPTOTIC PROCESS AUTOPHAGY SOD1 PARKINSON DISEASE

© 2020 Biovista Vizit All Rights Reserved.